Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases

Repurposing is an increasingly attractive method within the field of drug development for its efficiency at identifying new therapeutic opportunities among approved drugs at greatly reduced cost and time of more traditional methods. Repurposing has generated significant interest in the realm of rare...

Full description

Bibliographic Details
Main Authors: Anup P. Challa, Nicole M. Zaleski, Rebecca N. Jerome, Robert R. Lavieri, Jana K. Shirey-Rice, April Barnado, Christopher J. Lindsell, David M. Aronoff, Leslie J. Crofford, Raymond C. Harris, T. Alp Ikizler, Ingrid A. Mayer, Kenneth J. Holroyd, Jill M. Pulley
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Genetics
Subjects:
drug repurposing
evidence synthesis
rare diseases
machine learning
phenome wide association studies
precision medicine
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.707836/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2021.707836/full

Similar Items